Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  GENETIC TESTING
A Global Strategic Business Report

This report analyzes the worldwide markets for Genetic Testing in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 79 companies including many key and niche players worldwide such as Abbott Laboratories, Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad Laboratories, Celera Group, Clinical Data, Inc., Genzyme Genetics, Orchid Cellmark, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Roche Diagnostics, Corp., Roche Molecular Diagnostics Inc., and Sciona Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-1392  PAGES:    285
PRICE:    $3950  DATE:       October 2008
COMPANIES:  79  MARKET DATA TABLES:   65
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  GENETIC TESTING (Complete Report) Pages : 285   | $3950
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS4$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Prenatal Diagnosis .....I-3
Newborn Screening .....I-3
Pharmacogenetics/Pharmacogenomics .....I-3
  
   Predictive Testing .....I-4  
II. EXECUTIVE SUMMARY41$2250
  1. Overview.....II-14 $400  
   Progressing from Service Driven to Product-Driven Market.....II-1
Genetic Testing Outlook Brightens.....II-1
Issues & Trends Affecting the Market.....II-1
Challenges Faced.....II-1
1$100
   Online Approach Gains Momentum.....II-2
Recommendations of ACOG and ACGM Augments Demand for CF Testing.....II-2
1$100
   Ethical Issues & Need for Appropriate Regulating Policies.....II-3
Routine Clinical Testing Vs. Predictive Genetic Testing.....II-3
1$100
   Issues Related to Genetic Tests for Obesity.....II-4
Competition.....II-4
Table 1: Leading Players in the Worldwide Genetic Testing Market (2005): Percentage Breakdown by Value Sales for Roche Diagnostics / Affymetrix, Abbott Laboratories, Bio-Rad Laboratories, and Others (includes corresponding Graph/Chart).....II-4
1$300
  2. Product Overview.....II-57 $700  
   Preface to Genetic Testing.....II-5
Genetic Testing and its Applications.....II-5
1$100
   Gene Candidate and Genome Screen.....II-6
‘DNA Chip’ to Chip into Genetic Field.....II-6
Techniques Used to Identify Changes in Genes.....II-6
1$100
   Types of Genetic Testing.....II-71$100
   Steps in Genetic Testing Process.....II-81$100
   Limitations.....II-9
Risks and Other Limitations of Genetic Testing.....II-9
Medical Institutions to Reap the Benefits of Genetic Testing.....II-9
Pharmacogenetics/Pharmacogenomics.....II-9
1$100
   Review of Select Genetic Tests.....II-10
Cystic Fibrosis.....II-10
Breast and Ovarian Cancer.....II-10
Alzheimer's Disease.....II-10
Colorectal Cancer.....II-10
Haemochromatosis (HH).....II-10
1$100
   Cowden Syndrome.....II-11
Huntington's Disease.....II-11
Costs of Select Tests.....II-11
Table 2: Costs of Select Genetic Tests (includes corresponding Graph/Chart).....II-11
1$300
  3. Product Launches.....II-125 $500  
   Clinical Data Introduces Genetic Test for HCM.....II-12
Iverson Genetic Diagnostics Unveils Warfarin Sensitivity Tests.....II-12
HairDX Unveils New Test for Predicting Female Hair Loss.....II-12
HairDX Introduces Genetic Test for Male Baldness.....II-12
1$100
   Clinical Data Introduces Pharmacogenetic Test for Clozapine.....II-13
Seegene Launches 18-Plex Genotyping Test.....II-13
InterGenetics Introduces Onco Vue.....II-13
1$100
   Applied Biosystems Introduces Novel DNA Technologies.....II-14
Dabur Introduces CML Quest.....II-14
deCODE Launches deCODE T2.....II-14
DNAPrint Announces the Launch of Ancestry Indicator.....II-14
1$100
   Genzyme Unveils New Mutation Analysis Test.....II-15
Orchid BioSciences Introduces New Testing Kit.....II-15
Focus Diagnostics Introduces GenomEx(TM) Service.....II-15
Relative Genetics Introduces Y-chromosome haplogroup Service on Web Site.....II-15
Genzyme Unveils Upgraded CFplus Cystic Fibrosis (CF) Mutation Analysis.....II-15
1$100
   TMC Introduces AJP.....II-16
Genaissance Rolls Out FAMILION Test.....II-16
Tm Bioscience Rolls Out Tag-It Mutation Detection Kits.....II-16
1$100
  4. Recent Industry Activity.....II-1717 $1000  
   Pfizer Animal Health to Take Over Bovigen and Catapult Genetics.....II-17
DNA Testing Systems Inks Agreement with DNAPrint Genomics.....II-17
PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix.....II-17
Hologic Acquires Third Wave.....II-17
1$100
   Dako Denmark Receives FDA Approval for TOP2A FISH pharmDx Device.....II-18
Abbott Partners with Roche, OSI and Genentech.....II-18
Lab21 Partners with Amgen.....II-18
1$100
   Medical Solutions Acquires Autogen Bioclear.....II-19
Nanobac to Acquire DNAPrint Genomics.....II-19
HairDX and Bosley Join Hands for Offering Genetic Test for Baldness.....II-19
1$100
   Nioxin Inks Agreement with HairDX.....II-20
Orchid Cellmark Acquires ReliaGene Technologies.....II-20
Celera Takes Over Atria Genetics.....II-20
Roche Acquires 454 Life Sciences.....II-20
1$100
   BioServe and DNAPrint Genomics Form Strategic Alliance.....II-21
Gentris Divests Stake in Genetic Testing Unit.....II-21
LabCorp Announces Genetic Test Partnership for Bucindolol Prescription.....II-21
Newsham Genetics Takes Over Monsanto Choice Genetics.....II-21
1$100
   BioServe Takes Over Genomics Collaborative.....II-22
CytoDyn Completes Acquisition of Advanced Genetic Technologies.....II-22
Sorenson Genomics Takes Over Identigene.....II-22
Clinical Data Enters into a License Agreement with VCGS.....II-22
1$100
   Clinical Data Collaborates with George Washington University.....II-23
Luminex Takes Over TM Bioscience.....II-23
Schering-Plough Enters into a Contract with Warnex.....II-23
1$100
   Cepheid Acquires Sangtec.....II-24
Medco Collaborates with Mayo.....II-24
Lab21 to Offer CLDA’s Genetic Test for Cardiac Channelopathy.....II-24
Clinical Data Pockets Epidauros Biotechnologie.....II-24
1$100
   Beijing Adinovo Gene and GENDIA Ink Genetic Test Exchange Agreement.....II-25
Genetic Technologies Forms Alliance with UTEK.....II-25
QIAGEN Acquires Digene.....II-25
Luminex Inks Development Licensing Agreement with Mayo Clinic.....II-25
1$100
   Manipal Joins Hands with NorDiag.....II-26
Orchid BioSceinces Enters into an Agreement with Prion Diagnostica.....II-26
DNAPrint™ genomics to Purchase Ellipsis.....II-26
Tm Bioscience Inks a Pact with Maxxam Analytics.....II-26
1$100
   DNAPrint genomics Takes Over Trace Genetics.....II-27
Roche Diagnostics Inks a Licensing Agreement with Innogenetics.....II-27
Clinical Data Purchases Genaissance Pharmaceuticals.....II-27
Illumina Pockets CyVera Corporation.....II-27
Orchid Cellmark Inks Contract with Merial.....II-27
Sequenom Gains Noninvasive Prenatal Diagnostic IP Rights from Isis.....II-27
1$100
   TMC Inks a Pact with ARUP Laboratories.....II-28
Specialty Laboratories Accords with Roche.....II-28
TMC Ceases Licensing Agreement with Abbott.....II-28
Correlagen Diagnostics Collaborates with Children's Hospital Boston.....II-28
Edith Cowan University Strikes Deal with Solbec.....II-28
InterGenetics Join Hands with i.d.e.a.s......II-28
1$100
   Clinical Data Acquires Icoria.....II-29
SomaLogic Strikes a Deal with Quest Diagnostics.....II-29
DNAPrint Bags Grant from the Federal Government.....II-29
Tepnel Acquires Orchid’s Diagnostic Unit.....II-29
Lark Tech. Merges with Genaissance.....II-29
PRF in Alliance with Sydney Biotech.....II-29
1$100
   Osmetech and LGC Sign Licensing Pact.....II-30
TMC Signs a Pact with LabOne.....II-30
Abbott in Agreement with Atria.....II-30
Third Wave Grants Marketing and Distribution Rights to Innogenetics.....II-30
Orchid Bags Deal to Provide Testing Services to Immigrants to New Zealand.....II-30
1$100
   Tm Bioscience Contracts with Pharmacogenetics.....II-31
Genetic Technologies Grants License to Genzyme.....II-31
New Genetic Testing Identifies Gene Responsible for Alzheimer Disease.....II-31
Roche Licenses GeneChip® Technology from Affymetrix.....II-31
Genaissance Acquires DNA Sciences.....II-31
GTG Joins GENDIA Diagnostic Genetic Testing Network.....II-31
1$100
   Arch Collaborates with GeneLink to Market Formulations.....II-32
Roche Diagnostics and GIS to Develop SARS Detection Kit.....II-32
Roche Diagnostics in Agreement with Innogenetics.....II-32
Cenetron in Alliance with Roche Diagnostics.....II-32
Gribbles Establishes Gribbles Molecular Science, a New Genetic Testing Firm.....II-32
1$100
   Roche the First to Receive Clearance for Thrombophilia Genetic Disorder Tests.....II-33
Roche and DeCode Develop DNA-based Tests to Foretell Behavior.....II-33
Roche and deCODE Discover Changes in Gene Responsible for Osteoporosis.....II-33
Roche and deCODE Announce Discovery of New Gene Structures.....II-33
Mayo Contracts with Tm Bioscience.....II-33
1$100
  5. Technological Developments – Recent Past data.....II-341 $100  
   New Molecular Diagnostic device to Improve Genetic Tests for Alzheimer disease.....II-34
Deakin Clinic Offers PGD, a Sophisticated Testing for Genetic Disorders.....II-34
New Gene Mapping Method to Enhance Identification of Haplotype Block.....II-34
New Non-Invasive test a Better Indicator of Malignancy than the PSA Test.....II-34
1$100
  6. Focus on Select Global Players.....II-354 $400  
   Abbott Laboratories (USA).....II-35
Abbott Molecular Inc. (USA).....II-35
Applied Biosystems Inc. (USA).....II-35
AutoGenomics, Inc. (USA).....II-35
1$100
   BioRad Laboratories (USA).....II-36
Celera Group (USA).....II-36
Clinical Data, Inc. (USA).....II-36
Genzyme Genetics (USA).....II-36
1$100
   Orchid Cellmark, Inc (USA).....II-37
PerkinElmer Inc., (USA).....II-37
Quest Diagnostics, Inc. (USA).....II-37
1$100
   Roche Diagnostics, Corp. (Switzerland).....II-38
Roche Molecular Diagnostics Inc. (USA).....II-38
Sciona, Limited. (USA).....II-38
1$100
  7. Global Market Perspective.....II-39   
   Table 3: World Recent Past, Current & Future Market Analysis for Genetic Testing by Geographic Region – US, Canada,Japan, Europe and Rest of World Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....II-391$300
   Table 4: World long-term projections for Genetic Testing by Geographic Region – US, Canada,Japan, Europe and Rest of World Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding Graph/Chart).....II-401$300
   Table 5: World 10-Year Perspective for Genetic Testing by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart).....II-411$300
III. MARKET43$1950
  1. The United States.....III-124 $1175  
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Newborn Testing Gain Ground.....III-1
Table 6: US Prenatal and Newborn Genetic Testing Market (2000-2005): Annual Sales in US$ Million (includes corresponding Graph/Chart).....III-1
1$150
   Predictive Screening –Another Growth Area.....III-2
Direct-to-Consumer Testing- A Growing Market .....III-2
US Regulatory Environment.....III-2
1$75
   Genetic Testing Set for Big Boost with New Legislation.....III-3
DNA-Based Testing to Move Beyond Research Laboratories.....III-3
Key and Emerging Players in US.....III-3
Abbott Laboratories.....III-3
1$75
   Abbott Molecular Inc......III-4
Applied Biosystems Inc......III-4
AutoGenomics, Inc......III-4
BioRad Laboratories.....III-4
1$75
   Celera Group.....III-5
Clinical Data, Inc......III-5
Genova Diagnostics.....III-5
1$75
   Genzyme Genetics.....III-6
InterGenetics.....III-6
Myriad Genetic Laboratories, Inc......III-6
Nanogen, Inc......III-6
1$75
   Orchid Cellmark, Inc.....III-7
PerkinElmer, Inc.....III-7
Quest Diagnostics, Inc......III-7
1$75
   Roche Molecular Diagnostics Inc......III-8
Sciona, Limited......III-8
Product Launches.....III-8
4$300
   Strategic Developments.....III-1211$625
   B. Market Analytics.....III-23
Table 7: US Recent Past, Current & Future Analysis for Genetic Testing by Segment–Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-23

Table 8: US Long-term Projections for Genetic Testing by Segment–Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-23
1$150
   Table 9: US 10-Year Perspective for Genetic Testing by Segment–Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart).....III-24
1$150
  2. Canada.....III-254 $325  
   A. Market Analysis.....III-25
Canada, the Market to be Watched Out for.....III-25
Key Player .....III-25
Luminex Molecular Diagnostics .....III-25
Product Launches.....III-25
1$75
   Strategic Developments.....III-261$75
   B. Market Analytics.....III-27
Table 10: Canadian Recent Past, Current & Future Analysis for Genetic Testing – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-27
1$150
   Table 11: Canadian Long-term Projections for Genetic Testing – Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-28
1$150
  3. Japan.....III-292 $225  
   Market Analysis.....III-29
Table 12: Japanese Recent Past, Current & Future Analysis for Genetic Testing – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)......III-29
1$150
   Table 13: Japanese Long-term Projections for Genetic Testing – Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-30
1$150
  4. Europe.....III-319 $400  
   A. Market Analysis.....III-31
A Brief Overview of Legislations/Regulatory Policies in Select European
  Countries.....III-31
Government Encourages Genetic Testing in UK.....III-31
1$75
   Key and Emerging Players in Europe.....III-32
Biotage AB (Sweden).....III-32
1$75
   IMGM Laboratories GmbH (Germany).....III-33
Roche Diagnostics, Corp. (Switzerland).....III-33
Strategic Developments.....III-33
6$450
   B. Market Analytics.....III-39
Table 14: European Recent Past, Current & Future Analysis for Genetic Testing – Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)......III-39

Table 15: European Long-term Projections for Genetic Testing – Annual Sales Figures with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-39
1$150
  5. Rest of World.....III-404 $450  
   A. Market Analysis.....III-40
Asia & Latin America: The Future Markets for Genetic Testing.....III-40
Approval of Experiments on Human Embryos in New Zealand.....III-40
Singapore Sets Guidelines for Genetic Research and Testing.....III-40
1$75
   Product Launches.....III-41
Strategic Developments.....III-41
1$75
   B. Market Analytics.....III-42
Table 16: Rest of World market for Genetic Testing - Recent Past, Current & Future Analysis with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart).....III-42
1$150
   Table 17: Rest of World (*) Market for Genetic Testing Long-term Projections with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-431$150
IV. COMPETITIVE LANDSCAPE 190$995
  
Total Companies Profiled: 79 (including Divisions/Subsidiaries - 89)

Region/Country                 Players


The United States                 67
Canada                             3
Europe                            16
     Germany                       3
     The United Kingdom            5
     Rest of Europe                8
Asia-Pacific (Excluding Japan)     3
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2009, Global Industry Analysts, Inc., USA.